Theme: To encourage and assist the review of Tissue Typing, Immunogenetics and Transplantation Immunology

Immunogenetics 2016

Immunogenetics 2016

Track 01: Immunogenetics

A branch of immunology concerned with the interrelations of heredity, disease, and the immune system especially with regard to the way in which the genetic information required to produce the diversity of antibodies required by the immune system is stored in the genome, transmitted from one generation to the next, and expressed in the organism.

Related Conferences:

2nd International Congress on Neuroimmunology and Therapeutics, December 01-03, 2016 Atlanta, Georgia, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016, San Antonio, USA; 2nd International Conference on Antibodies, July 14-15, 2016, Philadelphia, USA; Annual Plant Genomics Conference, July 14-15, 2016, Brisbane, Australia; International Conference on Immunogenetics and Histocompatibility, December 01-02, San Antonio, USA; International HLA and Immunogenetics Workshop, September 6–10, 2017, Pacific Grove, USA; Annual Meeting of the American Society for Histocompatibility and Immunogenetics, September 26-30,  2016, Saint Louis, USA.

Track 02: Histocompatibility and Transplantation

The transplant of organs is one of the greatest therapeutic achievements of the twentieth century. In organ transplantation, the adaptive immunity is considered the main response exerted to the transplanted tissue, since the principal target of the immune response is the MHC (major histocompatibility complex) molecules expressed on the surface of donor cells. However, we should not forget that the innate and adaptive immunities are closely interrelated and should be viewed as complementary and cooperating.

Related Conferences:

International Conference on Mucosal Immunology, July 28-29, 2016, Melbourne, Australia; International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melborne, Australia;  2nd International Conference on Parasitology, August 01-03, 2016 Manchester, UK;  American Transplant Congress, 11-15 June, 2016, Boston, USA; Annual Congress-October 26-27, 2016 Chicago, Illinois, USA; Conference on Immunogenicity and Immunotoxicity , October 24-26, 2016 Chicago, Illinois, USA. 

 

Track 03: Immunology and Transplantation

Transplantation is the act of transferring cells, tissues, or organs from one site to another. Development of the field of organ and tissue transplantation has accelerated remarkably since the human major histocompatibility complex (MHC) was discovered in 1967. However, the immune system remains the most formidable barrier to transplantation as a routine medical treatment. The immune system has developed elaborate and effective mechanisms to combat foreign agents. Establishing immune tolerance in transplant recipients is essential for promoting the long-term survival of an allograft and for preventing the development of harmful graft-versus-host responses

Related Conferences:

International Conference on Mucosal Immunology, July 28-29, 2016, Melbourne, Australia; Conference on Immunogenicity and Immunotoxicity, October 24-26, 2016 Chicago, Illinois, USA; International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; 2ndInternational Conference on Parasitology, August 01-03, 2016 Manchester, UK;  American Transplant Congress, 11-15 June, 2016, Boston, USA.

Track 04: Hematopoietic Stem Cell Transplantation

A hematopoietic stem cell is a cell isolated from the blood or bone marrow that can renew itself and can differentiate to a variety of specialized cells. It have the capacity to mobilize out of the bone marrow into circulating blood and can undergo programmed cell death which called as Apoptosis.  Hematopoietic stem cells (HSCs) are multipotent, the self-renewing progenitor cells that develop from the mesodermal hemangioblast cells. Although these anticancer treatments are among the most effective available, they do not have a precise aim and can destroy normal cells as well. Hematopoietic stem cells in adult bone marrow self-proliferate and differentiate into erythroid, lymphoid (B cells and T cells) and myeloid lineages (granulocytes, megakaryocytes, and macrophages).

Related Conferences:

8th World Congress on Cell and Stem Cell Research, March 20-22, 2017 Orlando, Florida, USA; 5th International Conference on Cell and Gene Therapy, May 19-21, 2016, San Antonio, USA; Annual Conference on Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 9th International Conference on Molecular Cardiology  and Cellular Cardiology, August 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference on Tissue preservation and Bio-banking, Aug 18-19, 2016,  Portland, Oregon; Conference on Stem Cell Models of Neural Degeneration and Disease, August 04-05, 2016 Manchester, UK;  Conference on  Tissue Regeneration, September 12-14, 2016 Berlin, Germany;  7th Annual Conference on Stem Cells , August 04-05, 2016 Manchester, UK.

 

Track 05: Immunomics

Immunomics is an investigation of Immunome research by utilizing genome wide methodologies. It is the study of immune system regulation and response to pathogens using genome-wide approaches. Immunomics is a relatively new field of research which integrates the disciplines of immunology, genomics, proteomics, transcriptomics and bioinformatics to characterize the host-pathogen interface. Discussions on the rapid advances in molecular immunology, sophisticated tools and molecular databases are facilitating in-depth exploration of the Immunome.

Related Conferences:

International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on HIV and AIDS, 23-24 May, 2016, London, United Kingdom;  International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; Conference on AIDS, 17-22 July 2016, Durban, South Africa.

Track 06: Regulation of Gene Expression

Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. These products are often proteins, but in non-protein coding genes, such as transfer RNA (tRNA) or small nuclear RNA (snRNA) genes. Regulation of gene expression is thus critical to an organism's development. Regulation of gene expression refers to the control of the amount and timing of appearance of the functional product of a gene. Cyclin expression levels control progression through the eukaryotic cell cycle. Gene regulation gives the cell control over all structure and function, and is the basis for cellular differentiation, morphogenesis and the versatility and adaptability of any organism.

Related Conferences:

The European Human Genetics Conference, May 21-24, 2016, Barcelona, Spain; International Congress of Human Genetics, November 07- 08, 2016 Barcelona, Spain; 4th International Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin Germany; International Conference on Neuro Genetics, June 6-7, 2016, London, UK; 5th International Conference on Cancer Genomics, August 8-9, 2016, Las Vegas, USA.

 

Track 07: Genes & Immunity

Genes and Immunity emphasizes the studies that demonstrate genetic, genomic or functional variation in the immune system, and the basic control over the immune system. The emerging role for genes outside the MHC will be of particular interest. Genes and Immunity is dedicated to presenting functional immunogenetics, understands how this new field controls the immune system to maintain health and defining its role in disease development, progression and severity. Genes and Immunity emphasizes the emergence of functional immunogenetics and genomics and their role in understanding the immune system and the pathogenesis of immune-mediated diseases, including autoimmunity, infectious diseases, chronic inflammatory disorders and malignancy.

Related Conferences:

International Conference on Neuro Genetics, June 6-7, 2016, London, UK; The European Human Genetics Conference, May 21-24, 2016, Barcelona, Spain; 5th International Conference on Cancer Genomics, August 8-9, 2016, Las Vegas, USA; International Congress of Human Genetics, November 07- 08, 2016 Barcelona, Spain; 4th International Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin Germany.

 

Track 08: Immunobiology

Immunobiology is the branch of biology dealing with immunologic effects on such phenomena as infectious disease, growth and development, recognition phenomena, hypersensitivity, heredity, aging, cancer, and transplantation. The study of diseases caused by disorders of the immune system is clinical immunology. The disorders of the immune system fall into two broad categories: Immunodeficiency and Autoimmunity, Immunodeficiency: in this immune system fails to provide an adequate response. Autoimmunity: in this immune system attacks its own host's body. Immunobiology is the branch of biomedical science that deals with the response of an organism to antigenic challenge and its recognition.

 Related Conferences:

International Conference on Autoimmunity, Oct 13-15, 2016, Manchester, UK; International Conference on Innate Immunity, July 21-22, 2016, Berlin, Germany; European Immunology Conference, July 21-23, 2016, Berlin, Germany; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 10th Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; Immunology Conference , May 13–17, 2016, Seattle, USA; International Congress of Immunology, 21-16, August, 2016, Melbourne, Australia; International Conference on Molecular Biology, October 10-11, 2016 Dubai, UAE.

 

Track 09: Cancer Immunology

      Cancer Immunology is focused on three major areas, the basic mechanisms of cancer immunity, engineering immune-based therapies, and developing clinical trials to study these new therapies. Cancer Immunology & Immunotherapy (CII) has reported significant advances in the field of tumour immunology. Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells. Immunotherapies can be categorized as active, passive or hybrid. Active immunotherapy directs the immune system to attack tumour cells by targeting tumour-associated antigens (TAAs). Passive immunotherapies enhance existing anti-tumour responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

Related Conferences:

14th World Congress on Cancer Therapy, December 8-10, 2016, Dallas, USA; 13th Conference on Cancer Therapy, October 17-19, 2016, Dubai, UAE; 12th Euro Global Summit on Cancer Therapy, September 26-28, 2016, London, UK; International Conference on Cervical Cancer, September 22-23, 2016, Vienna, Austria; 2nd World Congress on Breast Cancer, September 19-21, 2016, Phoenix, USA; Cell Death, July 3-8, 2016 Gerona, Spain.

Track 10:  The Genetics of Complex Diseases

          A genetic disease is any disease that is caused by an abnormality in an individual's genome. The abnormality can range from minuscule to major -- from a discrete mutation in a single base in the DNA of a single gene to a gross chromosome abnormality involving the addition or subtraction of an entire chromosome or set of chromosomes. Some of the diseases are Alzheimer's disease, scleroderma, asthma, Parkinson's disease, multiple sclerosis, osteoporosis, connective tissue diseases, kidney diseases, autoimmune diseases.

Related Conferences:

The European Human Genetics Conference, May 21-24, 2016, Barcelona, Spain; Immunology Conference , May 13–17, 2016, Seattle, USA; International Congress of Immunology, 21-16, August, 2016, Melbourne, Australia; International Conference on Molecular Biology, October 10-11, 2016 Dubai, UAE. Conference on Stem Cell Models of Neural Degeneration and Disease, August 04-05, 2016 Manchester, UK.

 

Track 11: Osteoimmunology

Osteoimmunology is a new study between the immune system, the hemopoietic system and bone. Osteoimmunology is a field that studies a treatment or prevention of the bone related diseases caused by disorders of the immune system. These cells secrete inflammatory cytokines that promote bone resorption, as well as Wnt ligands that stimulate the bone formation. In addition, T cells regulate bone homeostasis by cross talking with BM stromal cells and osteoblastic cells via CD40 ligand (CD40L) and other stimulatory molecules. This research on the immune cells is relevant to bone and the hemopoietic function, reviews the role of lymphocytes as mediators of the effects of PTH and estrogen in bone and the hemopoietic system and discusses the implication of osteoimmunology for transplant medicine.

Related Conferences:

International Congress on Immunology, 21-16, August, 2016, Melbourne, Australia; Immunology 2016, May 13–17, 2016, Seattle, USA; Conference on Stem Cell Models of Neural Degeneration and Disease, August 04-05, 2016 Manchester, UK; International Congress of Immunology, 21-16, August, 2016, Melbourne, Australia; Conference on Immunogenicity and Immunotoxicity, October 24-26, 2016 Chicago, Illinois, USA.

Track 12:  Molecular Immunology

Immunology is a branch of biomedical science that covers the study of all aspects of the immune system in all organisms. It deals with the physiological functioning of the immune system in states of both health and diseases; malfunctions of the immune system in immunological disorders (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection); the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ and in vivo. Immunology has applications in several disciplines of science, and as such is further divided.

Related Conferences:

International Conference on Autoimmunity, October 13-15, 2016, Manchester, UK; International Conference on Innate Immunity, July 21-22, 2016, Berlin, Germany; European Immunology Conference, July 21-23, 2016, Berlin, Germany; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 10th Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; Immunology 2016, May 13–17, 2016, Seattle, USA; International Congress of Immunology, 21-16, August, 2016, Melbourne, Australia.

 

Track 13: Immunotherapy

Immunotherapy is a broad category of anti-cancer therapies that use the body’s immune system to fight cancer cells. These cells are different from normal cells, in that they do not die normally. Immunotherapy drugs are designed to alert the immune system about these mutated cells so it can locate and destroy them.  Cancer is being treated by immunotherapy. Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance in microbial disease. These are the active agents of immunotherapy.

Related Conferences:

International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on Mucosal Immunology, July 28-29, 2016, Melbourne, Australia; International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; 2ndInternational Conference on Parasitology, August 01-03, 2016 Manchester, UK;  American Transplant Congress, 11-15 Jun, 2016, Boston, USA.

 

Track 14: Diabetes immunogenetics

A complex interaction of both genetic and immunologic factors leads an autoimmune disease Type 1 diabetes mellitus (T1DM). T1DM usually has a relapsing remitting disease course with autoantibody and T cellular responses to islet auto antigens, which precede the clinical onset of the disease process. The immunological diagnosis of autoimmune diseases relies primarily on the detection of autoantibodies in the serum of T1DM patients. Although their pathogenic significance remains uncertain, they have the practical advantage of serving as surrogate biomarkers for predicting the clinical onset of T1DM.

Related Conferences:

9th Global Diabetelogists Annual Meeting , June 6-8, 2016, Dallas, USA; 2nd International Conference on Alternative Ayurvedic and Herbal Medicine for Diabetes, June 6-8, 2016, Beijing, China; European Immunology Conference, July 21-23, 2016, Berlin, Germany; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 10th Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; Immunology 2016, May 13–17, 2016, Seattle, USA; International Congress of Immunology, 21-16, August, 2016, Melbourne, Australia.

Track 15:  Multiple Sclerosis Immunogenetics

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and common cause of non-traumatic neurological disability in young adults. The likelihood for an individual to develop MS is strongly influenced by her or his ethnic background and family history of disease, suggesting that genetic susceptibility is a key determinant of risk. Over 100 loci have been firmly associated with susceptibility, whereas the main signal genome-wide maps to the class II region of the human leukocyte antigen (HLA) gene cluster and explains up to 10.5% of the genetic variance underlying risk. HLA-DRB1*15:01 has the strongest effect with an average odds ratio of 3.08.

Related Conferences:

International Conference on Spine and Spinal Disorders, June 30-July 2, 2016, Valencia, Spain; International Conference on Neuro Genetics, June 6-7, 2016, London, UK; International Conference on Neuro Interventional Radiology, June 13-15, 2016, Rome, Italy; International Conference on Mucosal Immunology, July 28-29, 2016, Melbourne, Australia; 6th World Congress on Neurology and Neurological disorders, September 28-30, 2016 Toronto, Canada; International Conference on Positive Psychology  and Cognitive Behavioural Therapy June 13-14, 2016 Philadelphia, Pennsylvania, USA.

Track 16: Population Genetics

The collection of all the alleles of all of the genes found within a freely interbreeding population is known as the gene pool of the population. It is the study of genetic variation within populations, and involves the examination and modelling of changes in the frequencies of genes and alleles in populations over space and time. Many of the genes found within a population will be polymorphic - that is, they will occur in a number of different alleles. The main process of evolution are natural selection, genetic drift, gene flow, mutation, and genetic recombination and they form an integral part of the theory that underpins population genetics. Genetics in this branch of biology which examines such phenomena as adaptation, speciation, population subdivision, and population structure. It directly impacts counselling, forensic medicine, and genetic screening.

Related Conferences:

Conference on Stem Cell Models of Neural Degeneration and Disease, August 04-05, 2016 Manchester, UK ; The European Human Genetics Conference, May 21-24, 2016, Barcelona, Spain; International Congress of Immunology, 21-16, August, 2016, Melbourne, Australia; International Conference on Molecular Biology, October 10-11, 2016 Dubai, UAE.

 

Track 17: HIV Immunogenetics

Host genetic variation is presently estimated to account for about one-fourth of the observed differences in control of HIV across infected individuals. HLA proteins play important roles in T-cell-mediated adaptive immunity by presenting immunodominant HIV epitopes to cytotoxic T lymphocytes (CTLs) and CD4(+) T cells. Of the genetic variants that have been shown to affect the natural history of HIV infection, the human leukocyte antigen (HLA) class I genes exhibit the strongest and most consistent association, underscoring a central role for CD8(+) T cells in resistance to the virus. Genetic and functional data also indicate a function for HLA in natural killer cell-mediated innate immunity against HIV by interacting with killer cell immunoglobulin-like receptors (KIR). We review the HLA and KIR associations with HIV disease and discuss the mechanisms underlying these associations.

Related Conferences:

International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on HIV and AIDS, 23-24 May, 2016, London, United Kingdom; Conference on AIDS, 17-22 July 2016, Durban, South Africa.

 

Track 18: Antigen Receptor Signaling

Multiprotein complexes made up of clonally variable antigen-binding chains-the heavy and light immunoglobulin chains in the B-cell receptor, and the TCRα and TCRβ chains in the T-cell receptor-that are associated with invariant accessory proteins.

Related Conferences:

5th International Conference on Cell and Gene Therapy, May 19-21, 2016, San Antonio, USA; Conference on Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 6th World Congress on Stem Cells , Feb 29-Mar 2, 2016, Philadelphia, USA; 9th International Conference on Molecular  Cardiology and Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference on Tissue preservation and Bio-banking, Aug 18-19, 2016,  Portland, Oregon; Conference on Molecular Growth and Cellular Growth and Regeneration, 10-14, January 2017 , Colorado, USA.

 

Track 19: Oxidative Signaling in T cells

Reactive oxygen species (ROS) are thought to have effects on T-cell function and proliferation. Low concentrations of ROS in T cells are a prerequisite for cell survival, and increased ROS accumulation can lead to apoptosis/necrosis. The cellular redox state of a T cell can also affect T-cell receptor signalling, skewing the immune response.

Related Conferences:

International Conference on Mucosal Immunology, July 28-29, 2016, Melbourne, Australia;  International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia ;  International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; 2ndInternational Conference on Parasitology, August 01-03, 2016 Manchester, UK.

 

Track 20: Antigen Processing

T cell recognition of antigen presenting cells depends on their expression of a spectrum of peptides bound to Major Histocompatibility Complex class I (MHC-I) and class II (MHC-II) molecules. Conversion of antigens from pathogens or transformed cells into MHC-I and MHC-II-bound peptides is critical for mounting protective T cell responses, and similar processing of self-proteins is necessary to establish and maintain tolerance.

Related Conferences:

5th International Conference on Cell and Gene Therapy  May 19-21, 2016, San Antonio, USA; 2nd International Conference on Antibodies, July 14-15, 2016, Philadelphia, USA; International Conference on Allergy, March 29-30, 2017, Philadelphia, USA; 5th European Immunology Conference, July 21-23, 2016 Berlin, Germany; 5th International Conference on Cell and Gene Therapy  May 19-21, 2016, San Antonio, USA; Annual Plant Genomics Conference, July 14-15, 2016, Brisbane, Australia; International Conference on Immunogenetics and Histocompatibility, December 01-02, 2016, San Antonio, USA; International Conference on HLA and Immunogenetics , September 06-10, 2017, Pacific Grove, USA; Annual Meeting for Histocompatibility and Immunogenetics, 26-30, September 2016, Saint Louis, USA. 

Track 21: Antigen  Presentation

Antigen presentation stimulates T cells to become either "cytotoxic" CD8+ cells or "helper" CD4+ cells. An antigen-presenting cell (APC) or accessory cell is a cell that displays foreign antigens complexed with major histocompatibility complexes (MHCs) on their surfaces; this process is known as antigen presentation.

Related Conferences:

International Conference on Lupus, 27-28 October, 2016, Chicago, USA; 5th International Conference on Immunology, 24-26 October, 2016, Chicago, USA; International Conference on Autoimmunity, October, 13-15, 2016, Manchester, UK; International Conference on Tumour Immunology and Immunotherapy, July 28-30, 2016, Melbourne, Australia; International Conference on Immunogenetics and Histocompatibility, December 01-02, 2016,San Antonio, USA;  Conference on Molecular Growth and Cellular Growth and Regeneration, November 28-29, 2016 Sao Paulo, Brazil.

Track 22: Market Analysis of Immunogenetics

Immunogenomics brings together explore bridge on basics of Genomics & Immunology to disclose significant global discoveries in Human Health. It provides a great platform to cover recent breakthroughs in Genomics, Immunology, new genomic tools and its associated areas of research. The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests.

Related Conferences:

5th International Conference on Gene Therapy and Cell Therapy, May 19-21, 2016, San Antonio, USA; 2nd International Conference on Antibodies, July 14-15, 2016, Philadelphia, USA; 2nd International Congress on Neuroimmunology and Therapeutics, December 01-03, 2016 Atlanta, Georgia, USA; Annual Plant Genomics Conference, July 14-15, 2016, Brisbane, Australia; International Conference on Immunogenetics and Histocompatibility, December 01-02,2016,San Antonio, USA; International Workshop on HLA and Immunogenetics , September 6–10, 2017, Pacific Grove, USA.

 

 

 

 

Immunogenetics 2016 provides true to the goal of providing quality continuing education in immunogenetics, histocompatibility and transplantation with cutting edge clinical testing for solid organ and stem cell transplantation, participated in the development of a unique desensitization protocol that is used worldwide, contributed to understanding the allogeneic response to transplantation, investigated the differing immunogenicity of HLA antigens, identified minor histocompatibility systems, conducted numerous studies in population genetics, contributed knowledge about the immunogenetics of diseases, and supported studies in vaccine development. We are delighted to invite you all to attend and register for the “International conference on Histocompatibility and Immunogenetics (Immunogenetics 2016)” which is going to be held during December 01-02, 2016 in San Antonio, USA

Conference series LLC Organizes Human Genetics congress along with 500+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

San Antonio is the 3rd largest city in the state of Texas and 7th largest in the United States. It's the 24th largest metropolitan area in the country, visited by more than 26 million annual visitors. San Antonio is a beautiful city at the axis of three different geological terrains: Hill Country, South Texas Plains and Prairie and Lakes. San Antonio is considered to be the cradle of Texan liberty.

San Antonio is home to five Fortune 500 companies and the South Texas Medical Center, the only medical research and care provider in the South Texas region. The major attractions in San Antonio are fine art museums, historical missions and plenty of amusement parks in addition to great dining and lots of drinking. The culture and people are vibrant and interesting. San Antonio's downtown is one of the liveliest in the nation.

Immunogenetics-2016 welcomes attendees, presenters, and exhibitors from all over the world to San Antonio, USA. We are delighted to invite you all to attend and register for the “International Conference on Histocompatibility and Immunogenetics” which is going to be held during December 01-02, 2016 at San Antonio, USA. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Immunogenetics-2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Immunogenetics-2016 organizing committee look forward to meet you at San Antonio, USA.

Market Analysis:

The global market for Immunogenetics reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019. An overview of the global market for cell-based assays available and currently used. Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018. Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery, and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use. Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand. Coverage of new technologies, trends, alliances, and mergers.

 

Immunology Summit-2014

Immunology Summit -2014 Report

With the trail of success of the previous conference, OMICS International hosted the 3rd International Conference and Exhibition on Clinical & Cellular Immunology during September 29-October 01, 2014 at Double Tree by Hilton Baltimore-BWI Airport, Baltimore, USA with the theme From Basic Immune Understanding to Clinical Breakthroughs”.  Benevolent response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from the Immunologists, scientists, researchers, students and leaders from the fields of Clinical and Cellular Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following 17 thought provoking and cerebrating scientific tracks:

  • Clinical Immunology
  • Cellular Immunology
  • Inflammatory/Autoimmune Diseases
  • Cancer and Tumor Immunobiology
  • Vaccines
  • Immunotherapy
  • Infectious Diseases and Immune System
  • Auto Immunity
  • Autoimmunity and Therapathies
  • Allergy and Therapathies
  • Antigen Processing
  • T-Cells and B-Cells
  • Neuro Immunology
  • Reproductive Immunology
  • Costimmulatory Pathways
  • Diagnostic Immunology
  • Technological Innovations in Immunology
  • Immunoinformatics and Systems Immunology
  • Rheumatology
  • Nutritional Immunology

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

  • Charles J. Malemud, Case Western Reserve University, USA
  • Michael G. Hanna, Vaccinogen, Inc., USA
  • Howard A Young, National Cancer Institute-Frederick, USA
  • Yongqun Oliver He, University of Michigan Medical School, USA
  • Warren J Leonard, National Institutes of Health, USA
  • Yehuda Shoenfeld, Tel-Aviv University, Israel                                                                                                  

 OMICS International offers its heartfelt appreciation to Societies and Organizations such as Vaccinogen, International Immunomics Society, AutoImmunity Network, BMJD, Labroots, Medical College of Wisconsin and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with OMICS group in supporting and making the conference a never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Immunology Summit-2014, OMICS Group is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza,"4th International Conference and Exhibition on Immunology" to be held during September 28-30, 2015 at Houston, USA.


Past Reports  Proceedings  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 01-02, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations